34583-83-0

Basic information

• Product Name: 7-nitro-2,3,4,5-tetrahydro-1H-benzo[d]azepine
• Synonyms: 7-nitro-2,3,4,5-tetrahydro-1H-benzo[d]azepine
• CAS NO: 34583-83-0
• Molecular Formula: C₁₀H₁₂N₂O₂
• Molecular Weight: 192.21448
• Mol File: 34583-83-0.mol
• Article Data: 19

Chemical Properties

• Boiling Point: 340.8°C at 760 mmHg
• Flash Point: 159.9°C
• Appearance: /
• Density: 1.187g/cm³
• Vapor Pressure: 8.4E-05mmHg at 25°C
• Refractive Index: 1.567
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: 7-nitro-2,3,4,5-tetrahydro-1H-benzo[d]azepine(CAS DataBase Reference)
• NIST Chemistry Reference: 7-nitro-2,3,4,5-tetrahydro-1H-benzo[d]azepine(34583-83-0)
• EPA Substance Registry System: 7-nitro-2,3,4,5-tetrahydro-1H-benzo[d]azepine(34583-83-0)

Safety Data

• Hazardous Substances Data: 34583-83-0(Hazardous Substances Data)

Usage

General Description

7-nitro-2,3,4,5-tetrahydro-1H-benzo[d]azepine is a chemical compound with the molecular formula C9H9N3O2. It is a nitro-substituted heterocyclic compound that is used in medicinal and pharmaceutical applications. This chemical has been studied for its potential as an antidepressant and anxiolytic agent. It has also been investigated for its potential as a dopamine receptor agonist and has shown promising results in preclinical studies. Additionally, 7-nitro-2,3,4,5-tetrahydro-1H-benzo[d]azepine has shown potential in the treatment of neurodegenerative diseases, such as Alzheimer's and Parkinson's. Further research into the pharmacological properties and potential therapeutic applications of this compound is ongoing.

InChI:InChI=1/C10H12N2O2/c13-12(14)10-2-1-8-3-5-11-6-4-9(8)7-10/h1-2,7,11H,3-6H2

Upstream product

• 34583-86-3 1-(7-nitro-1,2,4,5-tetrahydro-3H-benzo[d]azepin-3-yl)ethan-1-one 
• 4424-20-8 2,3,4,5-tetrahydro-1H-3-benzazepine 
• 118454-13-0 7-nitro-2,3,4,5-tetrahydro-1H-benzo[d]azepine nitrate salt 
• 158726-29-5 7-nitro-3-(trifluoroacetyl)-2,3,4,5-tetrahydro-1H-3-benzazepine 
• 1701-57-1 2,3,4,5-tetrahydro-1Hbenzo[b]azepine 
• 12401-86-4 sodium hydroxide 
• 1087197-65-6 C₁₀H₁₃N*HNO₃ 
• 10533-22-9 1-(1,2,4,5-tetrahydro-benzo[d]azepin-3-yl)-ethanone 
• 7500-53-0 1,2-Phenylenediacetic acid 
• 17378-99-3 2,2’-(1,2-phenylene)diethanol 
• 130800-04-3 1,2-phenylenebis(ethane-2,1-diyl) dimethanesulfonate 
• 176492-85-6 2,2'-(4-nitro-1,2-phenylene)diacetic acid 
• 176492-82-3 2,2'-(4-nitro-1,2-phenylene)bis(ethane-2,1-diyl) dimethanesulfonate 

Downstream Products

• 1016265-68-1 C₁₆H₁₆N₂O₄S 
• 1016265-71-6 C₁₈H₁₉N₃O₃ 
• 107393-73-7 2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-ylamine 
• 118454-24-3 7-amino-1,2,4,5-tetrahydro-benzo[d]azepine-3-carboxylic acid tert-butyl ester 
• 1616480-49-9 2,2,2-trifluoro-1-[7-iodo-8-(2-oxo-2-phenylethoxy)-1,2,4,5-tetrahydrobenzo[d]azepin-3-yl]ethan-1-one 
• 1616480-50-2 4-iodo-1-phenyl-7,8,9,10-tetrahydro-6H-3-oxa-8-azacyclohepta[e]indene 
• 1616479-83-4 1-phenyl-7,8,9,10-tetrahydro-6H-3-oxa-8-azacyclohepta[e]indene 
• 25174-38-3 7-Chlor-2,3,4,5-tetrahydro-1H-3-benzazepin 
• 1232397-12-4 [3-(2-methoxy-ethyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yl]-(7-phenyl-pyrrolo[2,1-f][1,2,4]triazin-2-yl)-amine 

Relevant articles and documents

BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS

The invention provides a compound of formula (0): or a pharmaceutically acceptable salt, N-oxide or tautomer thereof. The compounds are inhibitors of ERK 1/2 kinases and will be useful in the treatment of ERKl/2-mediated conditions. The compounds are therefore useful in therapy, in particular in the treatment of cancer.

HETEROCYCLIC COMPOUNDS AS AXL INHIBITORS

Compounds of Formula I and their uses of effective AXL inhibitors and for the treatment of physical condition mediated by AXL.

BENZAZEPINES AS SEROTONIN 5-HT2C RECEPTOR LIGANDS AND USES THEREOF

The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are benzaz